As global markets react to the recent U.S. election results, with major indices like the small-cap Russell 2000 seeing significant gains, investor optimism is fueled by expectations of growth-friendly ...
VistaGen Therapeutics, Inc. (NASDAQ:VTGN) Q2 2025 Earnings Call Transcript November 10, 2024 Operator: Good afternoon, ladies and gentlemen, and welcome to the Vistagen Therapeutics Fiscal Year 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback